Table 5.

Comparison of quantification levels of anti-PLA2R antibodies among three groups after treatment

Groups	n	Quantification levels of anti-PLA2R antibodies (RU/mL)
Complete remission group	16	6.89±5.76
Partial remission group	24	12.74±9.18c
Non-remission group	16	274.36±359.48a,b
F		10.775
P		0

Notes: Compared with complete remission group,

^aP<0.05,

^cP<0.05; compared with the partial remission group,

^bP<0.01. After treatment, the serum levels of anti-PLA2R antibodies in the non-remission group were significantly higher than those in the complete remission group and partial remission group; the serum levels of anti-PLA2R antibodies in the partial remission group were higher than the complete remission group.